Advances in the Management of Alopecia Areata: The Evolving Role of JAK Inhibitors and the Dermatology Care Team

Advances in the Management of Alopecia Areata: The Evolving Role of JAK Inhibitors and the Dermatology Care Team is organized by Med Learning Group.

Release Date: January 12, 2022
Expiration Date: January 12, 2023

Program Overview:
This enduring activity is intended for dermatologists, pediatric dermatologists, and dermatology advanced providers (NPs and PAs) who are involved in the care and treatment of patients with alopecia areata. by RNs and APNs.

Learning Objectives:
After completing the CME enduring activity, learners should be better able to:

• Distinguish between the pathophysiology of alopecia areata and other causes of hair loss
• Use clinical trial data on the efficacy, safety, and durability of JAK inhibitors to recognize patients with AA who may benefit from these therapies
• Identify risk factors for disease progression and poor prognosis in patients with AA
• Develop treatment regimens for patients with AA that consider the psychosocial burden of the disease and associated autoimmune disorders